If the science itself makes it a large commercial opportunity it does NOT make sense for Pharma/VC/ Other parties not to engage.
They aren't just sitting around waiting to pick the remains off a dead carcass.
PAR inexperience in how and when to strike a deal is the real issue and NOT whether anyone was interested
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-118
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.020(8.70%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 24.0¢ | $103.5K | 427.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 181211 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 23253 | 4 |
View Market Depth
| Last trade - 10.48am 20/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |